{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:55:56Z","timestamp":1790564156932,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Vitamin K (VK) as a nutrient, is a cofactor in the carboxylation of osteocalcin (OC), which can bind with hydroxyapatite to promote bone mineralization and increase bone strength. However, some studies have been inconsistent on whether vitamin K2 (VK2) can maintain or improve bone mineral density (BMD) and reduce the incidence of fractures in postmenopausal women. Therefore, the main objective of this meta-analysis was to determine the effect of VK2 as a nutritional supplement on BMD and fracture incidence in postmenopausal women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, EMBASE, and Cochrane Library databases (published before March 17, 2022) and then extracted and pooled data from all randomized controlled trials (RCTs) that met the inclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixteen RCTs with a total of 6,425 subjects were included in this meta-analysis. The overall effect test of 10 studies showed a significant improvement in lumbar spine BMD (BMD LS) (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006) with VK2. The subgroup analysis of VK2 combination therapy showed that BMD LS was significantly maintained and improved with the administration of VK2 (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03). The overall effect test of the six RCTs showed no significant difference in fracture incidence between the two groups (RR=0.96, P=0.65). However, after excluding one heterogeneous study, the overall effect test showed a significant reduction in fracture incidence with VK2 (RR = 0.43,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01). In addition, this meta-analysis showed that VK2 reduced serum undercarboxylated osteocalcin (uc-OC) levels and the ratio of uc-OC to cOC in both subgroups of VK2 combined intervention and alone. However, for carboxylated osteocalcin (cOC), both subgroup analysis and overall effect test showed no significant effect of VK2 on it. And the pooled analysis of adverse reactions showed no significant difference between the VK2 and control groups (RR = 1.03, 95%CI 0.87 to 1.21,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.76).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of this meta-analysis seem to indicate that VK2 supplementation has a positive effect on the maintenance and improvement of BMD LS in postmenopausal women, and it can also reduce the fracture incidence, serum uc-OC levels and the ratio of uc-OC to cOC. In conclusion, VK2 can indirectly promote bone mineralization and increase bone strength.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2022.979649","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T06:49:20Z","timestamp":1660200560000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"10","author":[{"given":"Ming-ling","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-lang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-jia","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-da","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/mnfr.201300743","article-title":"The realm of vitamin K dependent proteins: shifting from coagulation toward calcification","volume":"58","author":"Willems","year":"2014","journal-title":"Mol Nutr Food Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-nutr-080508-141217","article-title":"Roles for vitamin K beyond coagulation","volume":"29","author":"Booth","year":"2009","journal-title":"Annu Rev Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"C1358","DOI":"10.1152\/ajpcell.00216.2009","article-title":"Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms","volume":"297","author":"Atkins","year":"2009","journal-title":"Am J Physiol Cell Physiol."},{"key":"B7","first-page":"171","article-title":"Synthesis of human osteocalcins: gamma-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition","volume":"7","author":"Nakao","year":"1994","journal-title":"Pept Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0083-6729(07)00016-7","article-title":"Vitamin K and bone health in adult humans","volume":"78","author":"B\u00fcgel","year":"2008","journal-title":"Vitam Horm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00198-020-05638-z","article-title":"The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial","volume":"32","author":"R\u00f8nn","year":"2021","journal-title":"Osteoporos Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1182\/blood-2006-08-040709","article-title":"Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7","volume":"109","author":"Schurgers","year":"2007","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00223-020-00669-4","article-title":"Effect of low-dose vitamin k2 supplementation on bone mineral density in middle-aged and elderly Chinese: a randomized controlled study","volume":"106","author":"Zhang","year":"2020","journal-title":"Calcif Tissue Int."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/126.suppl_4.1181S","article-title":"Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health","author":"Shearer","year":"1996","journal-title":"J Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"110540","DOI":"10.1016\/j.fct.2019.05.048","article-title":"A comparatively study of menaquinone-7 isolated from Cheonggukjang with vitamin K(1) and menaquinone-4 on osteoblastic cells differentiation and mineralization","volume":"131","author":"Wu","year":"2019","journal-title":"Food Chem Toxicol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/CIA.S54107","article-title":"Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial","volume":"9","author":"Jiang","year":"2014","journal-title":"Clin Interv Aging."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00198-013-2325-6","article-title":"Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women","volume":"24","author":"Knapen","year":"2013","journal-title":"Osteoporos Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0899-9007(00)00554-2","article-title":"Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk","volume":"17","author":"Kaneki","year":"2001","journal-title":"Nutrition."},{"key":"B17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1359\/jbmr.2000.15.3.515","article-title":"Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis","volume":"15","author":"Shiraki","year":"2000","journal-title":"J Bone Miner Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0378-5122(98)00114-5","article-title":"A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy","volume":"31","author":"Iwamoto","year":"1999","journal-title":"Maturitas."},{"key":"B19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejps.2011.04.019","article-title":"Prospective evaluation of Vitamin K2, Raloxifene and their co-administration in osteoporotic rats","volume":"43","author":"Tasci","year":"2011","journal-title":"Eur J Pharm Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1359\/jbmr.081254","article-title":"Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women","volume":"24","author":"Binkley","year":"2009","journal-title":"J Bone Miner Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00198-009-1126-4","article-title":"Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial","volume":"21","author":"Emaus","year":"2010","journal-title":"Osteoporos Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"b5463","DOI":"10.1136\/bmj.b5463","volume":"340","year":"2010","journal-title":"BMJ"},{"key":"B23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A pooled analysis of vitamin D dose requirements for fracture prevention","volume":"367","author":"Bischoff-Ferrari","year":"2012","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/BF00369212","article-title":"Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts","volume":"59","author":"Koshihara","year":"1996","journal-title":"Calcif Tissue Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/09513590600900402","article-title":"Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women","volume":"22","author":"Yasui","year":"2006","journal-title":"Gynecol Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00774-013-0490-5","article-title":"Effects of risedronate alone or combined with vitamin K2 on serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal osteoporosis","volume":"32","author":"Kasukawa","year":"2014","journal-title":"J Bone Miner Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00774-007-0823-3","article-title":"Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women","volume":"26","author":"Hirao","year":"2008","journal-title":"J Bone Miner Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00774-011-0287-3","article-title":"Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials","volume":"30","author":"Fang","year":"2012","journal-title":"J Bone Miner Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1039\/C9FO03063H","article-title":"The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials","volume":"11","author":"Kuang","year":"2020","journal-title":"Food Funct."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00198-019-04853-7","article-title":"The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Su","year":"2019","journal-title":"Osteoporos Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13018-021-02728-4","article-title":"The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials","volume":"16","author":"Hu","year":"2021","journal-title":"J Orthop Surg Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00198-014-2989-6","article-title":"Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials","volume":"26","author":"Huang","year":"2015","journal-title":"Osteoporos Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2165\/00044011-200929070-00005","article-title":"Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials","volume":"29","author":"Iwamoto","year":"2009","journal-title":"Clin Drug Investig."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3310\/hta13450","article-title":"Vitamin K to prevent fractures in older women: systematic review and economic evaluation","author":"Stevenson","year":"2009","journal-title":"Health Technol Assess."},{"key":"B35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods."},{"key":"B36","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ."},{"key":"B37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1530\/EJE-16-0498","article-title":"Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women","volume":"175","author":"R\u00f8nn","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00774-013-0472-7","article-title":"Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women","volume":"32","author":"Koitaya","year":"2014","journal-title":"J Bone Miner Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00774-008-0034-6","article-title":"Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study","volume":"27","author":"Shiraki","year":"2009","journal-title":"J Bone Miner Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00774-008-0008-8","article-title":"Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules","volume":"27","author":"Inoue","year":"2009","journal-title":"J Bone Miner Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00198-007-0337-9","article-title":"Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women","volume":"18","author":"Knapen","year":"2007","journal-title":"Osteoporos Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1447-0756.2006.00386.x","article-title":"Muharram, Rachman IA, Reksoprodjo S, Sekizawa A. Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia","volume":"32","author":"Purwosunu","year":"2006","journal-title":"J Obstet Gynaecol Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0378-5122(01)00275-4","article-title":"Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women","volume":"41","author":"Ushiroyama","year":"2002","journal-title":"Maturitas."},{"key":"B45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s007760100002","article-title":"Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate","volume":"6","author":"Iwamoto","year":"2001","journal-title":"J Orthop Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s007760070003","article-title":"Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis","volume":"5","author":"Iwamoto","year":"2000","journal-title":"J Orthop Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jcpe.12232","article-title":"Circulating undercarboxylated osteocalcin and gingival crevicular fluid tumour necrosis factor-\u03b1 in children","volume":"41","author":"K\u00e2","year":"2014","journal-title":"J Clin Periodontol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"Cd008482","DOI":"10.1002\/14651858.CD008482.pub6","article-title":"Vitamin K supplementation for cystic fibrosis","volume":"6","author":"Jagannath","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1172\/JCI116387","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women","volume":"91","author":"Szulc","year":"1993","journal-title":"J Clin Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.clnu.2010.02.010","article-title":"Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women","volume":"29","author":"Yamauchi","year":"2010","journal-title":"Clin Nutr."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.979649\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T06:49:23Z","timestamp":1660200563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.979649\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":50,"alternative-id":["10.3389\/fpubh.2022.979649"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.979649","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"article-number":"979649"}}